An enhancer within tumors provides a potential target for 'undruggable' MYC in pediatric medulloblastoma
Efforts to develop effective therapies for MYC-amplified Group 3 medulloblastoma (G3-MB) are hindered by an incomplete understanding of how MYC expression is controlled in these tumors. MYC, an oncogene, has long been considered ...
21 hours ago
0
1









